These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2034236)
1. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain. Wall SJ; Yasuda RP; Hory F; Flagg S; Martin BM; Ginns EI; Wolfe BB Mol Pharmacol; 1991 May; 39(5):643-9. PubMed ID: 2034236 [TBL] [Abstract][Full Text] [Related]
2. Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors. Li M; Yasuda RP; Wall SJ; Wellstein A; Wolfe BB Mol Pharmacol; 1991 Jul; 40(1):28-35. PubMed ID: 1857338 [TBL] [Abstract][Full Text] [Related]
3. Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines. Wall SJ; Yasuda RP; Li M; Wolfe BB Mol Pharmacol; 1991 Nov; 40(5):783-9. PubMed ID: 1944243 [TBL] [Abstract][Full Text] [Related]
4. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. Yasuda RP; Ciesla W; Flores LR; Wall SJ; Li M; Satkus SA; Weisstein JS; Spagnola BV; Wolfe BB Mol Pharmacol; 1993 Feb; 43(2):149-57. PubMed ID: 8429821 [TBL] [Abstract][Full Text] [Related]
5. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Luthin GR; Harkness J; Artymyshyn RP; Wolfe BB Mol Pharmacol; 1988 Sep; 34(3):327-33. PubMed ID: 3419425 [TBL] [Abstract][Full Text] [Related]
6. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain. Flynn DD; Mash DC Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852 [TBL] [Abstract][Full Text] [Related]
8. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells. Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649 [TBL] [Abstract][Full Text] [Related]
9. Subtype-specific antibodies for muscarinic cholinergic receptors. I. Characterization using transfected cells and avian and mammalian cardiac membranes. Mayanil CS; Richardson RM; Hosey MM Mol Pharmacol; 1991 Dec; 40(6):900-7. PubMed ID: 1758441 [TBL] [Abstract][Full Text] [Related]
10. Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man. Ryberg AT; Warfvinge G; Axelsson L; Soukup O; Götrick B; Tobin G Arch Oral Biol; 2008 Jan; 53(1):66-74. PubMed ID: 17825245 [TBL] [Abstract][Full Text] [Related]
11. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. Jakubík J; Bacáková L; el-Fakahany EE; Tucek S J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472 [TBL] [Abstract][Full Text] [Related]
12. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype. Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421 [TBL] [Abstract][Full Text] [Related]
13. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor. Ehlert FJ; Griffin MT; Glidden PF J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358 [TBL] [Abstract][Full Text] [Related]
18. Effects of organophosphate exposure on muscarinic acetylcholine receptor subtype mRNA levels in the adult rat. Yagle K; Costa LG Neurotoxicology; 1996; 17(2):523-30. PubMed ID: 8856746 [TBL] [Abstract][Full Text] [Related]
19. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217 [TBL] [Abstract][Full Text] [Related]
20. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors. Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]